DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 153 filers reported holding DIPLOMAT PHARMACY INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,079,000 | -57.9% | 538,742 | +46.8% | 2.34% | -64.9% |
| Q4 2018 | $4,939,000 | -46.9% | 366,932 | -23.4% | 6.66% | -20.5% |
| Q3 2018 | $9,298,000 | -19.5% | 479,018 | +6.0% | 8.38% | -22.9% |
| Q2 2018 | $11,554,000 | +2704.4% | 452,018 | +3653.1% | 10.87% | +2304.6% |
| Q4 2015 | $412,000 | – | 12,044 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 445,200 | $7,101,000 | 1.80% |
| Redmile Group, LLC | 1,254,342 | $20,007,000 | 1.30% |
| Irving Magee Investment Management | 166,505 | $2,656,000 | 1.02% |
| BROADVIEW ADVISORS LLC | 376,050 | $5,998,000 | 0.83% |
| Sivik Global Healthcare LLC | 101,000 | $1,611,000 | 0.75% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 5,455,461 | $87,015,000 | 0.64% |
| Iguana Healthcare Management, LLC | 75,000 | $1,196,000 | 0.59% |
| RIVERBRIDGE PARTNERS LLC | 1,464,286 | $23,355,000 | 0.47% |
| HERMES INVESTMENT MANAGEMENT LTD | 1,772,777 | $28,276,000 | 0.46% |
| Endurant Capital Management LP | 85,043 | $1,356,000 | 0.44% |